Biological E
  • About BE

    Company Profile

    Biological E Limited, the first private sector biological products company in India and the first pharmaceuticals company in South India.... read more

    History

    Biological E Limited has a tradition of concern for people and healthcare providers and a dedication to develop the highest quality... read more

    Management Philosophy

    Late Dr. Vijay Kumar Datla, our Chairman and Managing Director, the force behind Management's thrust, strongly believed... read more

    Careers

    • Career @ BE
    • Work Environment
    • Current Job Openings
  • Business Divisions

    Vaccines

    BE is the first Indian private company to enter into the vaccine field. Ever since, we have been leaders in vaccinology... read more

    Sera & Other Biologics

    Biological E Limited is the first private sector Biological Products company in India. Today Biological E. has a formidable... read more

    Pharma

    From 1977 Biological E Limited has focused on building its pharmaceutical business in India... read more

    • Branded Formulations
    • Generics
    • API
    • Expansion

    Public Markets

    As the first private sector manufacturer of vaccines and pharmaceutical products in India, Biological E Limited has built up a countrywide distribution... read more

  • Product Portfolio

    Domestic Vaccines

    Biological E. Limited products have been used to protect millions of Indians, through immunization, ever since its inception as a pioneer read more

    API

    Biological E Limited has been a manufacturer of Active Pharmaceutical Ingredients for many years. The manufacture of these products was initially meant for our own captive needs read more

    Domestic Pharma

    When Biological E Limited was incorporated as Biological Products Private Limited in 1953, it became the pioneer in the manufacturing of Heparin in India. read more

    • Anti infective
    • Anticoagulants
    • Analgesics & Antipyretic
    • Gastrointestinal Therapy
    • Nutraceuticals
    • Respiratory Therapy

    International Vaccines

    BE supplies several essential and lifesaving Vaccines and Pharmaceuticals to UN Agencies viz.UNICEF, Pan American Health Organisations, other global markets read more

    International Pharma

    BE supplies several essential and lifesaving Vaccines and Pharmaceuticals to UN Agencies viz.UNICEF, Pan American Health Organisations, other global markets read more

    • Anticoagulants
    • Gastrointestinal Therapy
    • Nutraceuticals
    • Respiratory Therapy
  • Business Capabilites

    Manufacturing

    BE facility at Genome Valley, Hyderabad is one of the largest biotech manufacturing sites in Asia. We have recently invested to introduce two new processing suites... read more

    Sales & Distribution

    Biological E has a dedicated Vaccine Sales and Marketing team which reaches out more than 8000 Doctors
    and has a strong network of CFAs and Vaccine Distributors... read more

    Quality

    Our Quality Control laboratories are equipped with routinely... read more

    • Assurance
    • Accreditation

    Marketing

    BE is currently exporting its products to many countries across the globe, which includes APIs, Finished formulations and Biologics. read more

  • Research & Development

    Clinical Research

    The CRA team consists of young, dynamic, passionate and enthusiastic research professionals. They are capable of meeting... read more

    R & D Cycle

    Drug discovery is the process by which drugs are discovered, designed and then developed. Despite advances in technology... read more

    Partnerships

    Biological E.Limited currently has productive partnerships with several well respected and renowned Institutions and Public Health Services... read more

    Research Pipeline

    BE features a broad range of promising projects in various stages of development. Some of which are highlighted read more

  • Media
    • News
    • Gallery
  • Contact us
  • Research & Development
  • Research Pipeline
  • R & D Cycle

    • Discovery
    • Research & Development
    • Clinical Research
  • Clinical Research

  • Partnerships

  • Research Pipeline

BE features a broad range of promising projects in various stages of development. Some of which are highlighted below:

VACCINES IN PIPELINE

Liquid Hexavalent Vaccine : In 2013, GlaxoSmithKline and Biological E partnered to develop liquid hexavalent vaccine. The vaccine comprises of diphtheria, tetanus, whole cell pertussis, inactivated polio, haemophilus influenzae type B and hepatitis B.

Pneumococcal Conjugate Vaccine : Biological E is developing a pneumococcal conjugate vaccine comprising of 13 pneumo serotypes.

Typhoid Conjugate Vaccine : Biological E entered into a technology transfer arrangement with Novartis Vaccine Institute for Global Health (NVGH) in 2013. NVGH had completed Phase 2 trial prior to the technology transfer.

Paratyphoid Vaccine : In addition to the typhoid conjugate vaccine, Novartis Vaccine Institute for Global Health (NVGH) has licensed paratyphoid vaccine technology to Biological E.

Measles Rubella Vaccine : Biological E is developing a measles rubella vaccine. In 2013, Biological E received a commercial grant for this vaccine from Bill and Melinda Gates Foundation.

Inactivated Polio Vaccine : Biological E and Statens Serum Institut (SSI) entered into a technology transfer arrangement for inactivated polio vaccine in 2013 and technology transfer was started immediately. Currently in-house process improvement is being done at Nantes, France.

Inactivated Rotavirus Vaccine : Biological E licensed the technology from Centre for Disease Control and Prevention (CDC) in 2012 and the vaccine is being developed at the company’s facility in Nantes.

Meningitis Vaccine : In 2014, Biological E has started research in order to develop a Men ACWY vaccine.

Biological E respects intellectual property owned by others. Products that are protected under valid patents in respective jurisdictions are not offered or supplied for commercial use. Use of products protected by patent are intended solely for the purpose of Research & Development and for generating data for regulatory submissions.

© 2017 Biological E